{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:44:15Z","timestamp":1790948655509,"version":"4.1.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007102","name":"Zagazig University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03097-5","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T11:22:26Z","timestamp":1744888946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["RETRACTED ARTICLE: Nasal In-Situ Gels of Brij\u00ae-Enriched Novasomes as Optimistic Nanovesicular Carriers for Enhancing Anti-Depressant Action of Agomelatine"],"prefix":"10.1208","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9415-4267","authenticated-orcid":false,"given":"Tarek M.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3484-192X","authenticated-orcid":false,"given":"Ayman M.","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1615-2776","authenticated-orcid":false,"given":"Nourhan A.","family":"Abdulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"3097_CR1","unstructured":"World Health Organization (WHO). Depression [Internet]. 2023 [cited 2024 Nov 14]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression."},{"key":"3097_CR2","doi-asserted-by":"crossref","unstructured":"Xu J, Zhu C, Jin P, Sun W, Yu E. Agomelatine prevented depression in the chronic restraint stress model through enhanced catalase activity and halted oxidative stress. Abdel-Daim M, editor. PLOS ONE. 2024;19:e0289248.","DOI":"10.1371\/journal.pone.0289248"},{"key":"3097_CR3","doi-asserted-by":"publisher","first-page":"104974","DOI":"10.1016\/j.jddst.2023.104974","volume":"88","author":"AM Fathi","year":"2023","unstructured":"Fathi AM, Eissa RG, Balata GF, Ghazy F-ES, Eissa NG. Intranasal thermosensitive hydrogel of agomelatine solid dispersion for better management of depression. J Drug Deliv Sci Technol. 2023;88:104974.","journal-title":"J Drug Deliv Sci Technol."},{"key":"3097_CR4","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.3390\/pharmaceutics15112521","volume":"15","author":"MH Abdallah","year":"2023","unstructured":"Abdallah MH, El-Horany HE-S, El-Nahas HM, Ibrahim TM. Tailoring risperidone-loaded glycethosomal in situ gels using box-behnken design for treatment of schizophrenia-induced rats via intranasal route. Pharmaceutics. 2023;15:2521.","journal-title":"Pharmaceutics."},{"key":"3097_CR5","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.jsps.2021.11.006","volume":"29","author":"NA Abdulla","year":"2021","unstructured":"Abdulla NA, Balata GF, El-ghamry HA, Gomaa E. Intranasal delivery of Clozapine using nanoemulsion-based in-situ gels: An approach for bioavailability enhancement. Saudi Pharm J. 2021;29:1466\u201385.","journal-title":"Saudi Pharm J"},{"key":"3097_CR6","doi-asserted-by":"publisher","first-page":"123259","DOI":"10.1016\/j.ijpharm.2023.123259","volume":"643","author":"MY Zakaria","year":"2023","unstructured":"Zakaria MY, Eraqi WA, Mohamed SA. Ultra-deformable free fatty acid based nano-carriers for topical delivery of Luteolin: A potential paradigm for management of Methicillin-Resistant Staphylococcus aureus skin infections. Int J Pharm. 2023;643:123259.","journal-title":"Int J Pharm"},{"key":"3097_CR7","doi-asserted-by":"publisher","first-page":"105369","DOI":"10.1016\/j.jddst.2024.105369","volume":"92","author":"HN ElShagea","year":"2024","unstructured":"ElShagea HN, Makar RR, Salama AH, Elkasabgy NA, Salama A, Basalious EB. Terpene-augmented novasomal gels for the sustainment of rasagiline mesylate delivery; A new approach for treating Parkinson\u2019s disease induced by rotenone in rats. J Drug Deliv Sci Technol. 2024;92:105369.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3097_CR8","doi-asserted-by":"publisher","first-page":"104455","DOI":"10.1016\/j.jddst.2023.104455","volume":"84","author":"TM Ibrahim","year":"2023","unstructured":"Ibrahim TM. Exploitation of transdermal nanobilosomal gel platforms for ameliorating anti-diabetic activity of empagliflozin following I-optimal design. J Drug Deliv Sci Technol. 2023;84:104455.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3097_CR9","doi-asserted-by":"publisher","first-page":"102234","DOI":"10.1016\/j.jddst.2020.102234","volume":"61","author":"M Masjedi","year":"2021","unstructured":"Masjedi M, Montahaei T. An illustrated review on nonionic surfactant vesicles (niosomes) as an approach in modern drug delivery: Fabrication, characterization, pharmaceutical, and cosmetic applications. J Drug Deliv Sci Technol. 2021;61:102234.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3097_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/pharmaceutics15010026","volume":"15","author":"SM Hashem","year":"2022","unstructured":"Hashem SM, Gad MK, Anwar HM, Saleh NM, Shamma RN, Elsherif NI. Itraconazole-loaded ufasomes: evaluation, characterization, and anti-fungal activity against Candida albicans. Pharmaceutics. 2022;15:26.","journal-title":"Pharmaceutics"},{"key":"3097_CR11","first-page":"35","volume":"2","author":"AI Rosalina","year":"2023","unstructured":"Rosalina AI, Sagita E, Iskandarsyah I. Novasome: Combining Ufasome and Niosome for Excellent Vesicular Drug Delivery System. Sci Pharm. 2023;2:35\u201349.","journal-title":"Sci Pharm"},{"key":"3097_CR12","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.3390\/molecules27092936","volume":"27","author":"I Fatima","year":"2022","unstructured":"Fatima I, Rasul A, Shah S, Saadullah M, Islam N, Khames A, et al. Novasomes as nano-vesicular carriers to enhance topical delivery of fluconazole: a new approach to treat fungal infections. Molecules. 2022;27:2936.","journal-title":"Molecules"},{"key":"3097_CR13","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1080\/10717544.2022.2092236","volume":"29","author":"MH Elkomy","year":"2022","unstructured":"Elkomy MH, El Menshawe SF, Kharshoum RM, Abdeltwab AM, Hussein RRS, Hamad DS, et al. Innovative pulmonary targeting of terbutaline sulfate-laded novasomes for non-invasive tackling of asthma: statistical optimization and comparative in vitro \/ in vivo evaluation. Drug Deliv. 2022;29:2058\u201371.","journal-title":"Drug Deliv"},{"key":"3097_CR14","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1080\/10717544.2016.1183721","volume":"23","author":"RMA Abd-Elal","year":"2016","unstructured":"Abd-Elal RMA, Shamma RN, Rashed HM, Bendas ER. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency. Drug Deliv. 2016;23:3374\u201386.","journal-title":"Drug Deliv"},{"key":"3097_CR15","first-page":"31","volume-title":"Nanocosmetics: delivery approaches, applications and regulatory aspects","author":"A Dey","year":"2023","unstructured":"Dey A, Bubey SK. Nano-cosmetics-principle and classification. In: Kesharwani P, Dubey SK, editors. Nanocosmetics: delivery approaches, applications and regulatory aspects. Florida: CRC Press; 2023. p. 31\u201346."},{"key":"3097_CR16","unstructured":"Pinsky MA. Materials and methods for delivering antioxidants into the skin (patent No 20100098752A1). 2010."},{"key":"3097_CR17","doi-asserted-by":"publisher","first-page":"103032","DOI":"10.1016\/j.jddst.2021.103032","volume":"67","author":"B Atef","year":"2022","unstructured":"Atef B, Ishak RAH, Badawy SS, Osman R. Exploring the potential of oleic acid in nanotechnology-mediated dermal drug delivery: An up-to-date review. J Drug Deliv Sci Technol. 2022;67:103032.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3097_CR18","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1080\/10717544.2022.2103600","volume":"29","author":"S Ahmed","year":"2022","unstructured":"Ahmed S, Amin MM, El-Korany SM, Sayed S. Corneal targeted fenticonazole nitrate-loaded novasomes for the management of ocular candidiasis: Preparation, in vitro characterization, ex vivo and in vivo assessments. Drug Deliv. 2022;29:2428\u201341.","journal-title":"Drug Deliv"},{"key":"3097_CR19","doi-asserted-by":"publisher","first-page":"2179129","DOI":"10.1080\/10717544.2023.2179129","volume":"30","author":"S Ahmed","year":"2023","unstructured":"Ahmed S, Amin MM, Sayed S. A comprehensive review on recent nanosystems for enhancing antifungal activity of fenticonazole nitrate from different routes of administration. Drug Deliv. 2023;30:2179129.","journal-title":"Drug Deliv"},{"key":"3097_CR20","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1080\/10717544.2022.2057619","volume":"29","author":"R Albash","year":"2022","unstructured":"Albash R, Ragaie MH, Hassab MAE, El-Haggar R, Eldehna WM, Al-Rashood ST, et al. Fenticonazole nitrate loaded trans-novasomes for effective management of tinea corporis: design characterization, in silico study, and exploratory clinical appraisal. Drug Deliv. 2022;29:1100\u201311.","journal-title":"Drug Deliv"},{"key":"3097_CR21","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jconrel.2022.10.059","volume":"352","author":"M Rawas-Qalaji","year":"2022","unstructured":"Rawas-Qalaji M, Thu HE, Hussain Z. Oromucosal delivery of macromolecules: Challenges and recent developments to improve bioavailability. J Controlled Release. 2022;352:726\u201346.","journal-title":"J Controlled Release"},{"key":"3097_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2174\/156720108785915078","volume":"5","author":"S Jain","year":"2008","unstructured":"Jain S, Tiwary A, Jain N. PEGylated Elastic Liposomal Formulation for Lymphatic Targeting of Zidovudine. Curr Drug Deliv. 2008;5:275\u201381.","journal-title":"Curr Drug Deliv"},{"key":"3097_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122274","volume":"628","author":"P Deng","year":"2022","unstructured":"Deng P, Athary Abdulhaleem MF, Masoud RE, Alamoudi WM, Zakaria MY. Employment of PEGylated ultra-deformable transferosomes for transdermal delivery of tapentadol with boosted bioavailability and analgesic activity in post-surgical pain. Int J Pharm. 2022;628: 122274.","journal-title":"Int J Pharm"},{"key":"3097_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.colsurfb.2013.04.045","volume":"110","author":"E Vega","year":"2013","unstructured":"Vega E, Egea MA, Gardu\u00f1o-Ram\u00edrez ML, Garc\u00eda ML, S\u00e1nchez E, Espina M, et al. Flurbiprofen PLGA-PEG nanospheres: Role of hydroxy-\u03b2-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy. Colloids Surf B Biointerfaces. 2013;110:339\u201346.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3097_CR25","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.3390\/pharmaceutics15092259","volume":"15","author":"S Gulshan","year":"2023","unstructured":"Gulshan S, Shah S, Shah PA, Irfan M, Saadullah M, Abbas G, et al. Development and pharmacokinetic evaluation of novasomes for the trans-nasal delivery of fluvoxamine using arachidonic acid-carboxymethyl chitosan conjugate. Pharmaceutics. 2023;15:2259.","journal-title":"Pharmaceutics"},{"key":"3097_CR26","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/gels9080645","volume":"9","author":"IS Kurniawansyah","year":"2023","unstructured":"Kurniawansyah IS, Rusdiana T, Sopyan I, Desy Arya IF, Wahab HA, Nurzanah D. Comparative study of in situ gel formulation based on the physico-chemical aspect: systematic review. Gels. 2023;9:645.","journal-title":"Gels"},{"key":"3097_CR27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.colsurfb.2019.05.016","volume":"181","author":"S Ahmed","year":"2019","unstructured":"Ahmed S, Gull A, Mohd Aqil, Danish Ansari M, Sultana Y. Poloxamer-407 thickened lipid colloidal system of agomelatine for brain targeting: Characterization, brain pharmacokinetic study and behavioral study on Wistar rats. Colloids Surf B Biointerfaces. 2019;181:426\u201336.","journal-title":"Colloids Surf B Biointerfaces."},{"key":"3097_CR28","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.2147\/DDDT.S102500","volume":"11","author":"A Fatouh","year":"2017","unstructured":"Fatouh A, Elshafeey A, Abdelbary A. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics. Drug Des Devel Ther. 2017;11:1815\u201325.","journal-title":"Drug Des Devel Ther"},{"key":"3097_CR29","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/10717544.2017.1357148","volume":"24","author":"AM Fatouh","year":"2017","unstructured":"Fatouh AM, Elshafeey AH, Abdelbary A. Agomelatine-based in situ gels for brain targeting via the nasal route: statistical optimization, in vitro, and in vivo evaluation. Drug Deliv. 2017;24:1077\u201385.","journal-title":"Drug Deliv"},{"key":"3097_CR30","doi-asserted-by":"publisher","first-page":"121006","DOI":"10.1016\/j.ijpharm.2021.121006","volume":"607","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Mahmood S, Danish Ansari M, Gull A, Sharma N, Sultana Y. Nanostructured lipid carrier to overcome stratum corneum barrier for the delivery of agomelatine in rat brain; formula optimization, characterization and brain distribution study. Int J Pharm. 2021;607:121006.","journal-title":"Int J Pharm"},{"key":"3097_CR31","doi-asserted-by":"publisher","first-page":"112537","DOI":"10.1016\/j.colsurfb.2022.112537","volume":"216","author":"M Gul","year":"2022","unstructured":"Gul M, Shah FA, Sahar N, Malik I, Din FU, Khan SA, et al. Formulation optimization, in vitro and in vivo evaluation of agomelatine-loaded nanostructured lipid carriers for augmented antidepressant effects. Colloids Surf B Biointerfaces. 2022;216:112537.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3097_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1208\/s12249-021-02147-y","volume":"22","author":"MA Tawfik","year":"2021","unstructured":"Tawfik MA, Mohamed MI, Tadros MI, El-Helaly SN. Low-frequency sonophoresis as an active approach to potentiate the transdermal delivery of agomelatine-loaded novasomes: design, optimization, and pharmacokinetic profiling in rabbits. AAPS PharmSciTech. 2021;22:261.","journal-title":"AAPS PharmSciTech"},{"key":"3097_CR33","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4155\/tde-2019-0060","volume":"10","author":"P Jani","year":"2019","unstructured":"Jani P, Vanza J, Pandya N, Tandel H. Formulation of polymeric nanoparticles of antidepressant drug for intranasal delivery. Ther Deliv. 2019;10:683\u201396.","journal-title":"Ther Deliv"},{"key":"3097_CR34","doi-asserted-by":"publisher","first-page":"105564","DOI":"10.1016\/j.jddst.2024.105564","volume":"95","author":"S Alghareeb","year":"2024","unstructured":"Alghareeb S, Asare-Addo K, Conway BR, Adebisi AO. PLGA nanoparticles for nasal drug delivery. J Drug Deliv Sci Technol. 2024;95:105564.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3097_CR35","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.3390\/molecules27072309","volume":"27","author":"BK Shukla","year":"2022","unstructured":"Shukla BK, Rawat S, Gautam MK, Bhandari H, Garg S, Singh J. Photocatalytic Degradation of Orange G Dye by Using Bismuth Molybdate: Photocatalysis Optimization and Modeling via Definitive Screening Designs. Molecules. 2022;27:2309.","journal-title":"Molecules"},{"key":"3097_CR36","doi-asserted-by":"crossref","unstructured":"Abdallah MH, Shahien MM, El-Horany HE-S, Ahmed EH, El-Nahas HM, Abdulla NA, et al. Evaluation of mucoadhesive nano-bilosomal in situ gels containing anti-psychotic clozapine for treatment of schizophrenia: in vitro and in vivo studies. Pharmaceuticals. 2024;17:1404.","DOI":"10.3390\/ph17101404"},{"key":"3097_CR37","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1080\/10717544.2022.2100513","volume":"29","author":"AA Nemr","year":"2022","unstructured":"Nemr AA, El-Mahrouk GM, Badie HA. Hyaluronic acid-enriched bilosomes: an approach to enhance ocular delivery of agomelatine via D-optimal design: formulation, in vitro characterization, and in vivo pharmacodynamic evaluation in rabbits. Drug Deliv. 2022;29:2343\u201356.","journal-title":"Drug Deliv"},{"key":"3097_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105395","volume":"92","author":"TM Ibrahim","year":"2024","unstructured":"Ibrahim TM, Abdulla NA, Mohamed MA. Investigating the efficacy of mirtazapine-embedded invasomal gel nanocarriers via I-optimal design for management of atopic dermatitis. J Drug Deliv Sci Technol. 2024;92: 105395.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3097_CR39","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.26538\/tjnpr\/v6i9.12","volume":"6","author":"M Alkotaji","year":"2022","unstructured":"Alkotaji M, Ismail S, Alnori H. Nasal in-situ gel of inert cellulose for allergic rhinitis. Trop J Nat Prod Res. 2022;6:1414\u20139.","journal-title":"Trop J Nat Prod Res"},{"key":"3097_CR40","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/pat.4009","volume":"28","author":"O Pinkas","year":"2017","unstructured":"Pinkas O, Haneman O, Chemke O, Zilberman M. Fiber-reinforced composite hydrogels for bioadhesive and sealant applications: Fiber-reinforced Composite Bioadhesives. Polym Adv Technol. 2017;28:1162\u20139.","journal-title":"Polym Adv Technol"},{"key":"3097_CR41","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1038\/ncomms5095","volume":"5","author":"MC Giano","year":"2014","unstructured":"Giano MC, Ibrahim Z, Medina SH, Sarhane KA, Christensen JM, Yamada Y, et al. Injectable bioadhesive hydrogels with innate antibacterial properties. Nat Commun. 2014;5:4095.","journal-title":"Nat Commun"},{"key":"3097_CR42","doi-asserted-by":"publisher","first-page":"2164094","DOI":"10.1080\/10717544.2022.2164094","volume":"30","author":"WH Abdulaal","year":"2023","unstructured":"Abdulaal WH, Hosny KM, Alhakamy NA, Bakhaidar RB, Almuhanna Y, Sabei FY, et al. Fabrication, assessment, and optimization of alendronate sodium nanoemulsion-based injectable in-situ gel formulation for management of osteoporosis. Drug Deliv. 2023;30:2164094.","journal-title":"Drug Deliv"},{"key":"3097_CR43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/gels9060494","volume":"9","author":"MH Abdallah","year":"2023","unstructured":"Abdallah MH, Abu Lila AS, El-Nahas HM, Ibrahim TM. Optimization of potential nanoemulgels for boosting transdermal glimepiride delivery and upgrading its anti-diabetic activity. Gels. 2023;9:494.","journal-title":"Gels"},{"key":"3097_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jad.2016.03.017","volume":"197","author":"Q Ding","year":"2016","unstructured":"Ding Q, Li H, Tian X, Shen Z, Wang X, Mo F, et al. Zinc and imipramine reverse the depression-like behavior in mice induced by chronic restraint stress. J Affect Disord. 2016;197:100\u20136.","journal-title":"J Affect Disord"},{"key":"3097_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1208\/s12249-024-02814-w","volume":"25","author":"MM Faisal","year":"2024","unstructured":"Faisal MM, Gomaa E, Ibrahim AE, El Deeb S, Al-Harrasi A, Ibrahim TM. Verapamil-loaded cubosomes for enhancing intranasal drug delivery: development, characterization, ex vivo permeation, and brain biodistribution studies. AAPS PharmSciTech. 2024;25:95.","journal-title":"AAPS PharmSciTech"},{"key":"3097_CR46","doi-asserted-by":"publisher","first-page":"101791","DOI":"10.1016\/j.jddst.2020.101791","volume":"58","author":"VG Sita","year":"2020","unstructured":"Sita VG, Jadhav D, Vavia P. Niosomes for nose-to-brain delivery of bromocriptine: Formulation development, efficacy evaluation and toxicity profiling. J Drug Deliv Sci Technol. 2020;58:101791.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3097_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"A Nair","year":"2016","unstructured":"Nair A, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27.","journal-title":"J Basic Clin Pharm"},{"key":"3097_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.hest.2020.02.004","volume":"1","author":"D Chen","year":"2020","unstructured":"Chen D, Wang J, Xing Y, Jia P, Zhang Y, Wang J, et al. Behavioral assessment of post-stroke depression and anxiety in rodents. Brain Hemorrhages. 2020;1:105\u201311.","journal-title":"Brain Hemorrhages"},{"key":"3097_CR49","doi-asserted-by":"publisher","first-page":"114934","DOI":"10.1016\/j.bbr.2024.114934","volume":"465","author":"C Ge","year":"2024","unstructured":"Ge C, Wang S, Wu X, Lei L. Quercetin attenuates brain apoptosis in mice with chronic unpredictable mild stress-induced depression. Behav Brain Res. 2024;465:114934.","journal-title":"Behav Brain Res"},{"key":"3097_CR50","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1016\/j.xphs.2018.06.001","volume":"107","author":"JM Goldman","year":"2018","unstructured":"Goldman JM, More HT, Yee O, Borgeson E, Remy B, Rowe J, et al. Optimization of primary drying in lyophilization during early-phase drug development using a definitive screening design with formulation and process factors. J Pharm Sci. 2018;107:2592\u2013600.","journal-title":"J Pharm Sci"},{"key":"3097_CR51","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.3390\/molecules26165048","volume":"26","author":"MS Elsayed","year":"2021","unstructured":"Elsayed MS, Eldadamony NM, Alrdahe SST, Saber WIA. Definitive screening design and artificial neural network for modeling a rapid biodegradation of date palm fronds by a new trichoderma sp. PWN6 into Citric Acid. Molecules. 2021;26:5048.","journal-title":"Molecules."},{"key":"3097_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40436-020-00336-9","volume":"9","author":"OA Mohamed","year":"2021","unstructured":"Mohamed OA, Masood SH, Bhowmik JL. Modeling, analysis, and optimization of dimensional accuracy of FDM-fabricated parts using definitive screening design and deep learning feedforward artificial neural network. Adv Manuf. 2021;9:115\u201329.","journal-title":"Adv Manuf"},{"key":"3097_CR53","doi-asserted-by":"publisher","first-page":"100820","DOI":"10.1016\/j.scp.2022.100820","volume":"29","author":"H Moussa","year":"2022","unstructured":"Moussa H, Dahmoune F, Mahdjoub MM, Kadri N, Remini H. Definitive screening design and I-optimal design for optimization of ultrasound-assisted extraction of phenolic content and antioxidant capacity from Salvia officinalis L. leaves. Sustain Chem Pharm. 2022;29:100820.","journal-title":"Sustain Chem Pharm."},{"key":"3097_CR54","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3390\/pharmaceutics14091867","volume":"14","author":"TM Ibrahim","year":"2022","unstructured":"Ibrahim TM, Ayoub MM, El-Bassossy HM, El-Nahas HM, Gomaa E. Investigation of alogliptin-loaded in situ gel implants by 23 factorial design with glycemic assessment in rats. Pharmaceutics. 2022;14:1867.","journal-title":"Pharmaceutics"},{"key":"3097_CR55","doi-asserted-by":"crossref","unstructured":"Mosallam S, Ragaie MH, Moftah NH, Elshafeey AH, Abdelbary AA. Use of novasomes as a vesicular carrier for improving the topical delivery of terconazole: in vitro characterization, in vivo assessment and exploratory clinical experimentation. Int J Nanomedicine. 2021; 16:119\u201332.","DOI":"10.2147\/IJN.S287383"},{"key":"3097_CR56","doi-asserted-by":"crossref","unstructured":"Aboud HM, Hussein AK, Zayan AZ, Makram TS, Sarhan MO, El-Sharawy DM. Tailoring of selenium-plated novasomes for fine-tuning pharmacokinetic and tumor uptake of quercetin: in vitro optimization and in vivo radiobiodistribution assessment in ehrlich tumor-bearing mice. Pharmaceutics. 2022;14:875.","DOI":"10.3390\/pharmaceutics14040875"},{"key":"3097_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104957","volume":"88","author":"MM El Taweel","year":"2023","unstructured":"El Taweel MM, Tawfik MA, Soliman K, Khattab MS, Farag MM. Tailoring of topically applied curcumin loaded pro-novasomes for skin cancer treatment: In-vitro characterization, statistical optimization and histopathological assessment of subcutaneous Ehrlich carcinoma mice model. J Drug Deliv Sci Technol. 2023;88: 104957.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3097_CR58","doi-asserted-by":"crossref","unstructured":"Albassam NY, Kassab HJ. Diacerein loaded novasome for transdermal delivery: prepartion , in-vitro characterization and factors affecting formulation. Iraqi J Pharm Sci P-ISSN 1683 - 3597 E-ISSN 2521 - 3512. 2023;32:214\u201324.","DOI":"10.31351\/vol32issSuppl.pp214-224"},{"key":"3097_CR59","doi-asserted-by":"publisher","first-page":"6555","DOI":"10.2147\/IJN.S213613","volume":"14","author":"R Albash","year":"2019","unstructured":"Albash R, El-Nabarawi MA, Refai H, Abdelbary AA. Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment. Int J Nanomedicine. 2019;14:6555\u201374.","journal-title":"Int J Nanomedicine"},{"key":"3097_CR60","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/08982104.2018.1529793","volume":"29","author":"TM Ibrahim","year":"2019","unstructured":"Ibrahim TM, Abdallah MH, El-Megrab NA, El-Nahas HM. Transdermal ethosomal gel nanocarriers; a promising strategy for enhancement of anti-hypertensive effect of carvedilol. J Liposome Res. 2019;29:215\u201328.","journal-title":"J Liposome Res"},{"key":"3097_CR61","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1208\/s12249-008-9105-1","volume":"9","author":"G Abdelbary","year":"2008","unstructured":"Abdelbary G, El-gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech. 2008;9:740\u20137.","journal-title":"AAPS PharmSciTech"},{"key":"3097_CR62","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s10876-015-0908-4","volume":"26","author":"MA Mavaddati","year":"2015","unstructured":"Mavaddati MA, Moztarzadeh F, Baghbani F. Effect of Formulation and Processing Variables on Dexamethasone Entrapment and Release of Niosomes. J Clust Sci. 2015;26:2065\u201378.","journal-title":"J Clust Sci"},{"key":"3097_CR63","doi-asserted-by":"crossref","unstructured":"Ammar HO, Mohamed MI, Tadros MI, Fouly AA. Transdermal delivery of ondansetron hydrochloride via bilosomal systems: in vitro, ex vivo, and in vivo characterization studies. AAPS PharmSciTech. 2018;19:2276\u201387.","DOI":"10.1208\/s12249-018-1019-y"},{"key":"3097_CR64","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.2147\/IJN.S319348","volume":"16","author":"MA Abdelbari","year":"2021","unstructured":"Abdelbari MA, El-mancy SS, Elshafeey AH, Abdelbary AA. Implementing spanlastics for improving the ocular delivery of clotrimazole: in vitro characterization, ex vivo permeability, microbiological assessment and in vivo safety study. Int J Nanomedicine. 2021;16:6249\u201361.","journal-title":"Int J Nanomedicine"},{"key":"3097_CR65","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1080\/10717544.2019.1686087","volume":"26","author":"SF El Menshawe","year":"2019","unstructured":"El Menshawe SF, Nafady MM, Aboud HM, Kharshoum RM, Elkelawy AMMH, Hamad DS. Transdermal delivery of fluvastatin sodium via tailored spanlastic nanovesicles: mitigated Freund\u2019s adjuvant-induced rheumatoid arthritis in rats through suppressing p38 MAPK signaling pathway. Drug Deliv. 2019;26:1140\u201354.","journal-title":"Drug Deliv"},{"key":"3097_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08982104.2019.1577256","volume":"30","author":"MA El-Nabarawi","year":"2020","unstructured":"El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM. Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and in vivo skin deposition assay. J Liposome Res. 2020;30:1\u201311.","journal-title":"J Liposome Res"},{"key":"3097_CR67","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.2147\/IJN.S109565","volume":"11","author":"JK Kim","year":"2016","unstructured":"Kim JK, Zeb A, Qureshi OS, Kim H-S, Cha J-H, Kim H-S. Improved skin permeation of methotrexate via nanosized ultradeformable liposomes. Int J Nanomedicine. 2016;11:3813\u201324.","journal-title":"Int J Nanomedicine"},{"key":"3097_CR68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2017.03.039","volume":"254","author":"MO Mahmoud","year":"2017","unstructured":"Mahmoud MO, Aboud HM, Hassan AH, Ali AA, Johnston TP. Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats. J Controlled Release. 2017;254:10\u201322.","journal-title":"J Controlled Release"},{"key":"3097_CR69","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/10717544.2019.1609622","volume":"26","author":"A Emad Eldeeb","year":"2019","unstructured":"Emad Eldeeb A, Salah S, Ghorab M. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study. Drug Deliv. 2019;26:509\u201321.","journal-title":"Drug Deliv"},{"key":"3097_CR70","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1208\/s12249-022-02339-0","volume":"23","author":"A Ismail","year":"2022","unstructured":"Ismail A, Teiama M, Magdy B, Sakran W. Development of a novel bilosomal system for improved oral bioavailability of sertraline hydrochloride: formulation design, in vitro characterization, and ex vivo and in vivo studies. AAPS PharmSciTech. 2022;23:188.","journal-title":"AAPS PharmSciTech"},{"key":"3097_CR71","doi-asserted-by":"crossref","unstructured":"Zaki I, Abou-Elkhair RAI, Abu Almaaty AH, A. Abu Ali O, Fayad E, Ahmed Gaafar AG, et al. (2021) Design and synthesis of newly synthesized acrylamide derivatives as potential chemotherapeutic agents against MCF-7 breast cancer cell line lodged on pegylated bilosomal nano-vesicles for improving cytotoxic activity. Pharmaceuticals. 2021;14:1021.","DOI":"10.3390\/ph14101021"},{"key":"3097_CR72","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1080\/10717544.2022.2126028","volume":"29","author":"MY Zakaria","year":"2022","unstructured":"Zakaria MY, Zaki I, Alhomrani M, Alamri AS, Abdulaziz O, Abourehab MAS. Boosting the anti MERS-CoV activity and oral bioavailability of resveratrol via PEG-stabilized emulsomal nano-carrier: Factorial design, in-vitro and in-vivo assessments. Drug Deliv. 2022;29:3155\u201367.","journal-title":"Drug Deliv"},{"key":"3097_CR73","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/10717544.2018.1451572","volume":"25","author":"DE Aziz","year":"2018","unstructured":"Aziz DE, Abdelbary AA, Elassasy AI. Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation. Drug Deliv. 2018;25:815\u201326.","journal-title":"Drug Deliv"},{"key":"3097_CR74","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ijpharm.2010.06.034","volume":"397","author":"GM El Zaafarany","year":"2010","unstructured":"El Zaafarany GM, Awad GAS, Holayel SM, Mortada ND. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 2010;397:164\u201372.","journal-title":"Int J Pharm"},{"key":"3097_CR75","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ijpharm.2015.03.033","volume":"485","author":"AM Al-mahallawi","year":"2015","unstructured":"Al-mahallawi AM, Abdelbary AA, Aburahma MH. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Int J Pharm. 2015;485:329\u201340.","journal-title":"Int J Pharm"},{"key":"3097_CR76","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/ph15091106","volume":"15","author":"TM Mahmoud","year":"2022","unstructured":"Mahmoud TM, Nafady MM, Farouk HO, Mahmoud DM, Ahmed YM, Zaki RM, et al. Novel bile salt stabilized vesicles-mediated effective topical delivery of diclofenac sodium: a new therapeutic approach for pain and inflammation. Pharmaceuticals. 2022;15:1106.","journal-title":"Pharmaceuticals"},{"key":"3097_CR77","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s13346-019-00688-1","volume":"10","author":"SF El Menshawe","year":"2020","unstructured":"El Menshawe SF, Aboud HM, Elkomy MH, Kharshoum RM, Abdeltwab AM. A novel nanogel loaded with chitosan decorated bilosomes for transdermal delivery of terbutaline sulfate: artificial neural network optimization, in vitro characterization and in vivo evaluation. Drug Deliv Transl Res. 2020;10:471\u201385.","journal-title":"Drug Deliv Transl Res"},{"key":"3097_CR78","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1080\/02652048.2024.2395976","volume":"41","author":"HG Attia","year":"2024","unstructured":"Attia HG, Elmataeeshy ME, Aleraky M, Saleh SR, Ghareeb DA, El Demellawy MA, et al. The assessment of pharmacokinetics and neuroprotective effect of berberine hydrochloride-embedded albumin nanoparticles via various administration routes: comparative in-vivo studies in rats. J Microencapsul. 2024;41:576\u2013600.","journal-title":"J Microencapsul"},{"key":"3097_CR79","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/03639045.2017.1402922","volume":"44","author":"AA Matloub","year":"2018","unstructured":"Matloub AA, Salama AH, Aglan HA, AbouSamra MM, ElSouda SSM, Ahmed HH. Exploiting bilosomes for delivering bioactive polysaccharide isolated from Enteromorpha intestinalis for hacking hepatocellular carcinoma. Drug Dev Ind Pharm. 2018;44:523\u201334.","journal-title":"Drug Dev Ind Pharm"},{"key":"3097_CR80","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.fbio.2017.09.001","volume":"20","author":"S Sinthusamran","year":"2017","unstructured":"Sinthusamran S, Benjakul S, Swedlund PJ, Hemar Y. Physical and rheological properties of fish gelatin gel as influenced by \u03ba-carrageenan. Food Biosci. 2017;20:88\u201395.","journal-title":"Food Biosci"},{"key":"3097_CR81","doi-asserted-by":"publisher","first-page":"101778","DOI":"10.1016\/j.jddst.2020.101778","volume":"58","author":"RR Verekar","year":"2020","unstructured":"Verekar RR, Gurav SS, Bolmal U. Thermosensitive mucoadhesive in situ gel for intranasal delivery of Almotriptan malate: Formulation, characterization, and evaluation. J Drug Deliv Sci Technol. 2020;58:101778.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3097_CR82","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10847-010-9861-x","volume":"70","author":"HS Mahajan","year":"2011","unstructured":"Mahajan HS, Shah SK, Surana SJ. Nasal in situ gel containing hydroxy propyl \u03b2-cyclodextrin inclusion complex of artemether: development and in vitro evaluation. J Incl Phenom Macrocycl Chem. 2011;70:49\u201358.","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"3097_CR83","doi-asserted-by":"crossref","unstructured":"Wang Y, Jiang S, Wang H, Bie H. A mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases. Xu B, editor. PLOS ONE. 2017;12:e0189478.","DOI":"10.1371\/journal.pone.0189478"},{"key":"3097_CR84","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1208\/s12249-013-9921-9","volume":"14","author":"RMP Singh","year":"2013","unstructured":"Singh RMP, Kumar A, Pathak K. Thermally triggered mucoadhesive in situ gel of loratadine: \u03b2-cyclodextrin complex for nasal delivery. AAPS PharmSciTech. 2013;14:412\u201324.","journal-title":"AAPS PharmSciTech"},{"key":"3097_CR85","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3109\/10837450.2016.1163385","volume":"22","author":"S Ren\u00e7ber","year":"2017","unstructured":"Ren\u00e7ber S, Karavana SY, \u015eenyi\u011fit ZA, Era\u00e7 B, Limoncu MH, Balo\u011flu E. Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro\/in vivo evaluation. Pharm Dev Technol. 2017;22:551\u201361.","journal-title":"Pharm Dev Technol"},{"key":"3097_CR86","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2147\/IJN.S345505","volume":"17","author":"HF Salem","year":"2022","unstructured":"Salem HF, Nafady MM, Ali AA, Khalil NM, Elsisi AA. Evaluation of metformin hydrochloride tailoring bilosomes as an effective transdermal nanocarrier. Int J Nanomedicine. 2022;17:1185\u2013201.","journal-title":"Int J Nanomedicine"},{"key":"3097_CR87","doi-asserted-by":"publisher","first-page":"291","DOI":"10.31887\/DCNS.2008.10.3\/pgorwood","volume":"10","author":"P Gorwood","year":"2008","unstructured":"Gorwood P. Neurobiological mechanisms of anhedonia. Dialogues Clin Neurosci. 2008;10:291\u20139.","journal-title":"Dialogues Clin Neurosci"},{"key":"3097_CR88","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","volume":"13","author":"M-Y Liu","year":"2018","unstructured":"Liu M-Y, Yin C-Y, Zhu L-J, Zhu X-H, Xu C, Luo C-X, et al. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc. 2018;13:1686\u201398.","journal-title":"Nat Protoc"},{"key":"3097_CR89","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neulet.2017.08.019","volume":"658","author":"A Blasco-Serra","year":"2017","unstructured":"Blasco-Serra A, Gonz\u00e1lez-Soler EM, Cervera-Ferri A, Teruel-Mart\u00ed V, Valverde-Navarro AA. A standardization of the novelty-suppressed feeding test protocol in rats. Neurosci Lett. 2017;658:73\u20138.","journal-title":"Neurosci Lett"},{"key":"3097_CR90","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.3390\/pharmaceutics15082095","volume":"15","author":"MH Elkomy","year":"2023","unstructured":"Elkomy MH, Abo El-Ela FI, Zaki RM, Alsaidan OA, Elmowafy M, Zafar A, et al. Intranasal nanotransferosomal gel for quercetin brain targeting: II. Antidepressant effect in an experimental animal model. Pharmaceutics. 2023;15:2095.","journal-title":"Pharmaceutics."},{"key":"3097_CR91","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ibror.2019.01.001","volume":"6","author":"OJ Fasipe","year":"2019","unstructured":"Fasipe OJ. The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents. IBRO Rep. 2019;6:95\u2013110.","journal-title":"IBRO Rep"},{"key":"3097_CR92","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/npp.2012.140","volume":"38","author":"F Chenu","year":"2013","unstructured":"Chenu F, El Mansari M, Blier P. Electrophysiological effects of repeated administration of agomelatine on the dopamine, norepinephrine, and serotonin systems in the rat brain. Neuropsychopharmacology. 2013;38:275\u201384.","journal-title":"Neuropsychopharmacology"},{"key":"3097_CR93","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1007\/s00213-020-05580-2","volume":"237","author":"YA El-Khatib","year":"2020","unstructured":"El-Khatib YA, Sayed RH, Sallam NA, Zaki HF, Khattab MM. 17\u03b2-Estradiol augments the neuroprotective effect of agomelatine in depressive- and anxiety-like behaviors in ovariectomized rats. Psychopharmacology. 2020;237:2873\u201386.","journal-title":"Psychopharmacology"},{"key":"3097_CR94","doi-asserted-by":"crossref","unstructured":"Gumuslu E, Mutlu O, Sunnetci D, Ulak G, Celikyurt IK, Cine N, et al. The antidepressant agomelatine improves memory deterioration and upregulates CREB and BDNF Gene Expression Levels in Unpredictable Chronic Mild Stress (UCMS)-Exposed Mice. Drug Target Insights. 2014;8:DTI.S13870.","DOI":"10.4137\/DTI.S13870"},{"key":"3097_CR95","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.lfs.2018.09.003","volume":"210","author":"Y Lu","year":"2018","unstructured":"Lu Y, Ho CS, McIntyre RS, Wang W, Ho RC. Agomelatine-induced modulation of brain-derived neurotrophic factor (BDNF) in the rat hippocampus. Life Sci. 2018;210:177\u201384.","journal-title":"Life Sci"},{"key":"3097_CR96","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.bbamem.2009.06.022","volume":"1788","author":"S-D Li","year":"2009","unstructured":"Li S-D, Huang L. Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer. Biochim Biophys Acta BBA Biomembr. 2009;1788:2259\u201366.","journal-title":"Biochim Biophys Acta BBA Biomembr"}],"updated-by":[{"DOI":"10.1208\/s12249-026-03501-8","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000}}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03097-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03097-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03097-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T13:02:17Z","timestamp":1785502937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03097-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":96,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["3097"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03097-5","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1208\/s12249-026-03501-8","URL":"https:\/\/doi.org\/10.1208\/s12249-026-03501-8","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol of\n                      in-vivo\n                      study was approved according to the instructions of Institutional Animal Care and Use Committee (IACUC) of Faculty of Pharmacy, Zagazig University (approval number: ZU-IACUC\/3\/F\/339\/2023). The experiments complied with the ARRIVE guidelines and were performed conforming to EU Directive 2010\/63\/EU for animal experiments and the National Institutes of Health guide for the Care and Use of Laboratory Animals (NIH Publications No. 8023, revised 1978).","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"110"}}